Hannover Rück SE (HVRRY)

OTCMKTS · Delayed Price · Currency is USD
49.61
-0.02 (-0.03%)
Mar 26, 2025, 1:28 PM EST
11.36%
Market Cap 36.16B
Revenue (ttm) 27.39B
Net Income (ttm) 2.41B
Shares Out n/a
EPS (ttm) 19.99
PE Ratio 15.00
Forward PE n/a
Dividend 0.92 (1.89%)
Ex-Dividend Date May 7, 2024
Volume 38
Average Volume 4,745
Open 49.99
Previous Close 49.63
Day's Range 49.27 - 50.06
52-Week Range 38.40 - 50.36
Beta 0.56
RSI 64.56
Earnings Date Mar 13, 2025

About Hannover Rück SE

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally. It operates through Property & Casualty Reinsurance; and Life & Health Reinsurance segments. The company provides property and casualty reinsurance solutions for agricultural, livestock, and bloodstock; aviation and space; natural catastrophe; credit, surety, and political risks; cyber; facultative; and marine and offshore energy businesses, ... [Read more]

Sector Financials
Founded 1966
Employees 3,895
Stock Exchange OTCMKTS
Ticker Symbol HVRRY
Full Company Profile

Financial Performance

In 2024, Hannover Rück SE's revenue was 26.46 billion, an increase of 2.86% compared to the previous year's 25.72 billion. Earnings were 2.33 billion, an increase of 27.61%.

Financial numbers in EUR Financial Statements

News

Hannover Rück SE (HVRRF) Q4 2024 Earnings Conference Call Transcript

Hannover Rück SE (OTCPK:HVRRF) Q4 2024 Earnings Conference Call March 13, 2025 8:00 PM ET Company Participants Karl Steinle - General Manager Investor and Rating Agency Relations Jean-Jacques Henchoz ...

9 days ago - Seeking Alpha

Hannover Re: Expect More Special Dividends

4 weeks ago - Seeking Alpha

Chubb Ltd (CB) Partners with healthŌme and Hannover Re to Win 2024 Global Innovation Award

Chubb Ltd (CB) Partners with healthŌme and Hannover Re to Win 2024 Global Innovation Award

3 months ago - GuruFocus

healthŌme and Hannover Re Win 2024 Global Innovation Award for Genomics-Based Insurance Program

Award honors the integration of genomics into critical illness coverage, enhancing the value of life and critical illness products for insurers and policyholders. HUNTSVILLE, Ala. , Dec. 10, 2024 /PRN...

3 months ago - Benzinga

Hannover RE Is Not Attractive Enough For Long-Term Investors

Despite strong performance, Hannover RE may not be ideal for long-term investors due to premium valuation and low dividend yield.

4 months ago - Seeking Alpha

Hannover Re fully committed to narrowing protection gap, says CFO

Clemens Jungsthfel, the CFO of Hannover Re, discusses the German firm's third-quarter earnings and the economic impacts of climate change.

4 months ago - CNBC

Hurricane Beryl batters Europe's insurance stocks

Shares of European insurers fell sharply on Tuesday as Beryl became the earliest ever Category 5 storm to emerge in the Atlantic, raising fears of a long and damaging hurricane season.

9 months ago - Market Watch

Hannover Re CFO: Increased interest rates positive for business

Clemens Jungsthöfel, CFO at Hannover Re, discusses first-quarter earnings, and his outlook for operations in the face of a sticky inflationary environment.

2 years ago - CNBC International TV